Share this page:
The Use of Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient With Novel Coronavirus 2019 Infection: A Case Report
Remdesivir is a novel therapeutic with known activity against SARS CoV-2 and related coronaviruses. Remdesivir, as well as convalescent plasma therapy, are currently under investigation as potential therapies for patients with Coronavirus Disease 19 (COVID-19).
Date Last Updated (Year-Month-Day)
Anderson, Jonathon, Jordan Schauer, Suzanne Bryant, and Cornelia R. Graves. 2020. "The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report." Case Reports in Women's Health:e00221.